(Q72354142)
Statements
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients (English)
D Abigerges
G G Chabot
J P Armand
P Hérait
A Gouyette
scientific article published on 01 January 1995